Unlike other peptides that act through hormonal signaling, BPC157 works locally and systemically to accelerate cellular repair
If your research protocol needs more than one vial, mention it when placing your peptide order and we'll do our best to include extra vials as a courtesy, depending on order size
Synthesis & quality Manufactured via controlled, validated processes designed for high purity and lot-to-lot consistency
Mechanism and Side Effects of IGF-1 LR3 Aug 12022 IGF-1 LR3 is a synthetic protein and lengthened analogue of human insulin-like growth factor 1 (IGF-1).It differs from native IGF-1 in that it possesses an arginine instead of a glutamic acid at the third position in its amino acid sequence ("arginine 3"), and also has an additional 13 amino acids at its N-terminus (MFPAMPLLSLFVN) ("long"), for a total of 83 amino acids (relative to the 70 of IGF-1).The consequences of these modifications are that IGF-1 LR3 retains the pharmacological activity of IGF-1 as an agonist of the IGF-1 receptor, has very low affinity for the insulin-like growth factor-binding proteins (IGFBPs), and has improved metabolic stability
January 1, 2022
They reach that output by different routes, and that difference is the entire rationale for combining them
